• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特异性抗体有助于宿主抵御土拉热弗朗西斯菌全北区亚种菌株。

Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.

作者信息

Stenmark Stephan, Lindgren Helena, Tärnvik Arne, Sjöstedt Anders

机构信息

Department of Clinical Microbiology, Infectious Diseases, Umeå University, Umeå, Sweden.

出版信息

Microb Pathog. 2003 Aug;35(2):73-80. doi: 10.1016/s0882-4010(03)00095-0.

DOI:10.1016/s0882-4010(03)00095-0
PMID:12901846
Abstract

T cells are crucial to the control and eradication of the facultative intracellular bacterium Francisella tularensis. A contributory role of humoral antibodies in the host defence remains to be assessed. We used B-cell-deficient mice to study the possible contribution of antibodies to the defence against the live vaccine strain (LVS) or a clinical isolate of F. tularensis, both belonging to the subspecies holarctica (type B). When B-cell-deficient (Igmu(-/-)) mice of the C57BL/10 background were administered immune serum one day before intradermal injection of LVS, they developed lower bacterial numbers in skin, liver, and spleen than did mice receiving normal serum, and survived a challenge inoculum that was lethal for mice given normal serum. Administration of immune serum to C57BL/10 mice afforded protection also against infection with the clinical isolate of F. tularensis subsp. holarctica. Five days after intradermal inoculation of bacteria of the isolate, animals receiving immune serum showed 4log10 lower bacterial counts in liver and spleen than mice administered normal serum. In mice primed by LVS infection, T-cell immunity and host protection were strong and only a marginal contribution of immune serum against a secondary intradermal infection was demonstrated. Together, these findings show that specific antibodies contribute to the host defence of mice against F. tularensis subsp. holarctica.

摘要

T细胞对于兼性胞内细菌土拉弗朗西斯菌的控制和根除至关重要。体液抗体在宿主防御中的作用仍有待评估。我们使用B细胞缺陷小鼠来研究抗体对抵抗活疫苗株(LVS)或土拉弗朗西斯菌临床分离株(二者均属于全北区亚种(B型))的防御作用。当给C57BL/10背景的B细胞缺陷(Igmu(-/-))小鼠在皮内注射LVS前一天注射免疫血清时,它们皮肤、肝脏和脾脏中的细菌数量低于接受正常血清的小鼠,并且在接种对接受正常血清的小鼠具有致死性的攻击接种物后存活下来。给C57BL/10小鼠注射免疫血清也能提供针对土拉弗朗西斯菌全北区亚种临床分离株感染的保护。在皮内接种该分离株细菌五天后,接受免疫血清的动物肝脏和脾脏中的细菌数量比接受正常血清的小鼠低4个对数级。在由LVS感染引发免疫的小鼠中,T细胞免疫和宿主保护作用很强,仅显示免疫血清对二次皮内感染有微弱贡献。总之,这些发现表明特异性抗体有助于小鼠抵抗土拉弗朗西斯菌全北区亚种的宿主防御。

相似文献

1
Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.特异性抗体有助于宿主抵御土拉热弗朗西斯菌全北区亚种菌株。
Microb Pathog. 2003 Aug;35(2):73-80. doi: 10.1016/s0882-4010(03)00095-0.
2
Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.特异性抗体可保护γ射线辐照小鼠免受土拉弗朗西斯菌感染。
Microb Pathog. 2012 Nov-Dec;53(5-6):259-68. doi: 10.1016/j.micpath.2012.07.006. Epub 2012 Jul 25.
3
Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.用活兔热病疫苗人体接种者的血清对小鼠进行被动保护,使其免受致死性土拉热弗朗西斯菌(活兔热病疫苗株)感染。
Am J Med Sci. 1994 Aug;308(2):83-7. doi: 10.1097/00000441-199408000-00003.
4
Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.用土拉弗朗西斯菌活疫苗株(LVS)对小鼠进行口服免疫,可保护小鼠免受强毒A型土拉弗朗西斯菌的呼吸道攻击。
Vaccine. 2007 May 10;25(19):3781-91. doi: 10.1016/j.vaccine.2007.02.014. Epub 2007 Feb 26.
5
Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.土拉弗朗西斯菌感染衍生的单克隆抗体可用于检测、防护及治疗。
Clin Vaccine Immunol. 2009 Mar;16(3):414-22. doi: 10.1128/CVI.00362-08. Epub 2009 Jan 28.
6
Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.鉴定土拉弗朗西斯菌外膜蛋白 A(FopA)作为土拉菌病的保护性抗原。
Vaccine. 2011 Sep 16;29(40):6941-7. doi: 10.1016/j.vaccine.2011.07.075. Epub 2011 Jul 29.
7
Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.减毒活土拉弗朗西斯菌疫苗(LVS)在小鼠疾病模型中的疗效。
Vaccine. 2005 Apr 8;23(20):2680-6. doi: 10.1016/j.vaccine.2004.03.071.
8
Protection afforded against aerosol challenge by systemic immunisation with inactivated Francisella tularensis live vaccine strain (LVS).用灭活的土拉弗朗西斯菌活疫苗株(LVS)进行全身免疫对气溶胶攻击所提供的保护作用。
Microb Pathog. 2008 Feb;44(2):164-8. doi: 10.1016/j.micpath.2007.08.009. Epub 2007 Aug 21.
9
Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis.免疫缺陷小鼠对强毒株土拉弗朗西斯菌气溶胶感染和全身感染的易感性。
Microb Pathog. 2004 Jun;36(6):311-8. doi: 10.1016/j.micpath.2004.02.003.
10
Correlates of protection following vaccination of mice with gene deletion mutants of Francisella tularensis subspecies tularensis strain, SCHU S4 that elicit varying degrees of immunity to systemic and respiratory challenge with wild-type bacteria.经基因缺失突变的土拉弗朗西斯菌亚种土拉弗朗西斯菌 SCHU S4 菌株免疫接种的小鼠,对野生型细菌引起的全身和呼吸道挑战的保护相关性,其免疫程度存在差异。
Mol Immunol. 2013 May;54(1):58-67. doi: 10.1016/j.molimm.2012.10.043. Epub 2012 Nov 28.

引用本文的文献

1
Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle.利用海藻酸微胶囊化减毒弗朗西斯氏菌 LVS O 抗原突变体作为疫苗传递载体的模型。
PLoS One. 2022 Mar 11;17(3):e0259807. doi: 10.1371/journal.pone.0259807. eCollection 2022.
2
and Antibodies.以及抗体。
Microorganisms. 2021 Oct 12;9(10):2136. doi: 10.3390/microorganisms9102136.
3
A study of innate immune kinetics reveals a role for a chloride transporter in a virulent Francisella tularensis type B strain.
一项固有免疫动力学研究揭示了氯离子转运蛋白在毒力型弗朗西斯菌属 B 型菌株中的作用。
Microbiologyopen. 2021 Feb;10(2):e1170. doi: 10.1002/mbo3.1170.
4
Early infection-induced natural antibody response.早期感染诱导的天然抗体反应。
Sci Rep. 2021 Jan 15;11(1):1541. doi: 10.1038/s41598-021-81083-0.
5
Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.气溶胶初免-加强免疫接种可在外群兔中提供针对强毒A型土拉弗朗西斯菌的强大保护。
PLoS One. 2018 Oct 22;13(10):e0205928. doi: 10.1371/journal.pone.0205928. eCollection 2018.
6
Adaptive Immunity to and Considerations for Vaccine Development.适应性免疫与疫苗开发的考虑因素。
Front Cell Infect Microbiol. 2018 Apr 6;8:115. doi: 10.3389/fcimb.2018.00115. eCollection 2018.
7
Functional and structural characterization of Francisella tularensis O-antigen antibodies at the low end of antigen reactivity.在抗原反应性较低水平时土拉弗朗西斯菌O抗原抗体的功能和结构特征
Monoclon Antib Immunodiagn Immunother. 2014 Aug;33(4):235-45. doi: 10.1089/mab.2014.0022.
8
Enhancement of vaccine efficacy by expression of a TLR5 ligand in the defined live attenuated Francisella tularensis subsp. novicida strain U112ΔiglB::fljB.通过在确定的减毒活土拉弗朗西斯菌新凶手亚种U112ΔiglB::fljB菌株中表达Toll样受体5(TLR5)配体来增强疫苗效力。
Vaccine. 2014 Sep 8;32(40):5234-40. doi: 10.1016/j.vaccine.2014.07.038. Epub 2014 Jul 19.
9
B-cell epitopes in GroEL of Francisella tularensis.土拉弗朗西斯菌GroEL中的B细胞表位
PLoS One. 2014 Jun 26;9(6):e99847. doi: 10.1371/journal.pone.0099847. eCollection 2014.
10
Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?单核细胞/巨噬细胞对抗土拉弗朗西斯菌感染的炎症反应途径:可能的治疗靶点?
Front Cell Infect Microbiol. 2014 Feb 21;4:18. doi: 10.3389/fcimb.2014.00018. eCollection 2014.